Literature DB >> 7508682

New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues.

K Tóth1, M M Vaughan, H K Slocum, M A Arredondo, H Takita, R M Baker, Y M Rustum.   

Abstract

We have developed a new immunoperoxidase "sandwich" staining method for amplified detection of P-glycoprotein (Pgp) that is suitable for use on formalin-fixed, paraffin-embedded (conventional) tissue sections. This was accomplished by substantially changing the procedure described by Chan (1988) so as to increase specific staining intensity and to decrease nonspecific background staining. To determine the most appropriate primary antibody for the assay, we compared the immunoreactivity of JSB-1, C494, and C219 monoclonal antibodies recognizing internal epitopes of Pgp, and MRK16 and 4E3 monoclonal antibodies recognizing external epitopes of Pgp. Paraffin sections of Pgp-positive normal human tissues (adrenal, liver, kidney, and brain), of renal tumors, and of cell pellets of sensitive and multidrug resistant human tumor cell lines (MCF-7, KB) were used for comparisons. Immunostaining was excellent with JSB-1, moderate with C494, and very weak with C219. MRK16 and 4E3 showed no reaction. Nonspecific background staining was reduced by 1) omitting immunoglobulin G from secondary antibodies; 2) decreasing the concentration of peroxidase-antiperoxidase complex; and 3) utilizing casein solution for blocking and washing. Pretreatment of sections before immunostaining was also simplified. Using JSB-1, the threshold for detection of elevated Pgp corresponded to less than two-fold relative resistance to doxorubicin. Applying this method, we found two of 26 non-small cell lung cancers were positive for Pgp, consistent with previous results of others using frozen sections. This new immunoperoxidase sandwich staining method using JSB-1 now allows reliable Pgp detection in sections of formalin-fixed, paraffin-embedded (archived) surgical specimens and small biopsy materials commonly used for diagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508682      PMCID: PMC1887155     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines.

Authors:  H S Chan; G Bradley; P Thorner; G Haddad; B L Gallie; V Ling
Journal:  Lab Invest       Date:  1988-12       Impact factor: 5.662

2.  Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells.

Authors:  C R Fairchild; S P Ivy; C S Kao-Shan; J Whang-Peng; N Rosen; M A Israel; P W Melera; K H Cowan; M E Goldsmith
Journal:  Cancer Res       Date:  1987-10-01       Impact factor: 12.701

Review 3.  How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.

Authors:  M M Gottesman
Journal:  Cancer Res       Date:  1993-02-15       Impact factor: 12.701

4.  Immunohistochemical analysis of pulmonary and pleural tumors with the monoclonal antibody HYB-612 directed against the multidrug resistance (MDR-1) gene product, P-glycoprotein.

Authors:  J A Radosevich; P G Robinson; L S Rittmann-Grauer; B Wilson; J P Leung; M L Maminta; W Warren; S T Rosen; V E Gould
Journal:  Tumour Biol       Date:  1989

5.  Isolation and genetic characterization of human KB cell lines resistant to multiple drugs.

Authors:  S Akiyama; A Fojo; J A Hanover; I Pastan; M M Gottesman
Journal:  Somat Cell Mol Genet       Date:  1985-03

6.  Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance.

Authors:  R J Scheper; J W Bulte; J G Brakkee; J J Quak; E van der Schoot; A J Balm; C J Meijer; H J Broxterman; C M Kuiper; J Lankelma
Journal:  Int J Cancer       Date:  1988-09-15       Impact factor: 7.396

7.  Monoclonal antibody C219 detection of the multidrug-resistant protein P-glycoprotein in routinely processed tissues: a study of 36 cases of ovarian carcinoma.

Authors:  M L Rutledge; S S Robey-Cafferty; E G Silva; J M Bruner
Journal:  Mod Pathol       Date:  1990-05       Impact factor: 7.842

8.  Expression of a multidrug resistance gene in esophageal adenocarcinoma. Correlation with response to chemotherapy and comparison with gastric adenocarcinoma.

Authors:  S S Robey-Cafferty; M L Rutledge; J M Bruner
Journal:  Am J Clin Pathol       Date:  1990-01       Impact factor: 2.493

Review 9.  P-glycoproteins in pathology: the multidrug resistance gene family in humans.

Authors:  R S Weinstein; J R Kuszak; L F Kluskens; J S Coon
Journal:  Hum Pathol       Date:  1990-01       Impact factor: 3.466

10.  Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.

Authors:  H S Chan; P S Thorner; G Haddad; V Ling
Journal:  J Clin Oncol       Date:  1990-04       Impact factor: 44.544

View more
  10 in total

Review 1.  Transporter molecules in multidrug resistance.

Authors:  R J Scheper; G L Scheffer; M J Flens; P van der Valk; H J Broxterman; M A Izquierdo
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

2.  Double immunohistochemical staining method for HIF-1alpha and its regulators PHD2 and PHD3 in formalin-fixed paraffin-embedded tissues.

Authors:  Mary M Vaughan; Karoly Toth; Sreenivasulu Chintala; Youcef M Rustum
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-07

3.  Partial circumvention of P-glycoprotein-mediated multidrug resistance by doxorubicin-14-O-hemiadipate.

Authors:  Olga V Leontieva; Maria N Preobrazhenskaya; Ralph J Bernacki
Journal:  Invest New Drugs       Date:  2002-02       Impact factor: 3.850

4.  Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity.

Authors:  Jean-Marie Nicolas; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2019-05-28       Impact factor: 4.009

5.  MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.

Authors:  K Tóth; M M Vaughan; N S Peress; H K Slocum; Y M Rustum
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

6.  Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia.

Authors:  M Saegusa; Y Takano; I Okayasu
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.

Authors:  M Daood; C Tsai; M Ahdab-Barmada; J F Watchko
Journal:  Neuropediatrics       Date:  2009-01-22       Impact factor: 1.947

8.  Enhanced cellular proliferative activity and cell death in chronic thyroiditis and thyroid papillary carcinoma.

Authors:  I Okayasu; M Saegusa; M Fujiwara; Y Hara; N R Rose
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

9.  Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts.

Authors:  Y Takamiya; Y Abe; Y Tanaka; A Tsugu; M Kazuno; Y Oshika; K Maruo; Y Ohnishi; O Sato; H Yamazaki; H Kijima; Y Ueyama; N Tamaoki; M Nakamura
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo.

Authors:  Y Abe; Y Ohnishi; M Yoshimura; E Ota; Y Ozeki; Y Oshika; T Tokunaga; H Yamazaki; Y Ueyema; T Ogata; N Tamaoki; M Nakamura
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.